World Influenza Vaccines Market - Opportunities and Forecasts, 2017-2023

1. World Influenza Vaccines Market  Opportunities and Forecasts, 2017-2023

2. Influenza is a type of seasonal or pandemic condition causing fever, coryza, cough, headache, and malaise. The severity of influenza symptoms varies across age groups and type of influenza. According to the World Health Organization (WHO), approximately, 3 to 5 million people are prone to seasonal epidemics, annually. The growing number of ageing population and an increase in the frequency of seasonal influenza outbreak supplement the demand for influenza vaccines across the healthcare industry.

3. Intellectual property rights are providing security to the patent holders, thereby, increases their market share. However, the upcoming patent expirations for top influenza vaccines and the growing popularity of influenza drugs as over the counter (OTC) products would provide an opportunity for generic manufacturers. On the contrary, limited awareness regarding the availability of novel versions of vaccines and unclear reimbursement facilities hamper the growth of the influenza vaccines market. • Furthermore, high tolerance of viral strains towards conventional compositions would limit the adoption of influenza vaccines. However, collective efforts of governments, non-profitable organizations and pharmaceutical companies would help boost advance research and development programs, which would subsequently lead to a reduction in the cost of vaccines and also bring clarity in the reimbursement and regulatory guidelines. Furthermore, Clinical research success would play significant role for company that would lead to development of influenza vaccines.

4. KEY MARKET BENEFITS: • Inclusive intellects of factors driving the growth of the influenza drugs market is provided in the report. For instance, growing demand for anti-influenza drugs, increasing awareness and healthcare expenditures on sophisticated and efficient clinical facilities would drive the global influenza vaccines market • The projections in this report are derived by analysing the current market trends and market potential for the period of 20142020, in terms of value • Competitive intelligence (of leading manufacturers and distributors of vaccines) helps in understanding the competitive scenario across geographies • SWOT analysis of key market players is provided to illustrate the business strategies adopted by companies • An in-depth analysis of current research and clinical developments in the global influenza vaccines market is provided with key market dynamic factors that helps to understand the market behaviour

5. Key players in the market: • Sanofi • GlaxoSmithKline • Novartis • Abbott Laboratories • Mitsubishi Tanabe Pharma • Johnson & Johnson • Sinovac Biotech • Baxter International • F. Hoffmann-La Roche and AstraZeneca

6. KEY MARKET SEGMENTS: • Global influenza vaccines market is mainly segmented below: • Influenza Vaccines Market - By Type • nfluenza type A • nfluenza type B • nfluenza type C • Influenza Vaccines Market - By Demography • Paediatric • Adult • Influenza Vaccines Market - By Geography • North America • Europe • Asia-Pacific • LAMEA